The Valley Desk

ArticleThe Journal of dermatologyPublished

Guselkumab Safety in Patients With Latent Tuberculosis: Analysis of 11 Studies in Psoriatic Disease

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
The Journal of dermatology
Published
Subject terms
Humans; Arthritis, Psoriatic; Psoriasis; Antitubercular Agents; Treatment Outcome; Adult; Middle Aged; Female; Male; Interleukin-23; Randomized Controlled Trials as Topic; Clinical Trials, Phase II as Topic
PubMed ID
42226468
PubMed Central ID
PMC13341047
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal